PCHSX Mutual Fund

NAV$36.31

Fund Essentials - as of Feb 28, 2026

Net Assets
$30M
Expense Ratio
1.79%
Dividend Yield (Current)
2.73%
Holdings
119
Inception Date
Jul 26, 1999
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.60%
1 Year+20.62%
3 Year+10.56%
5 Year+13.08%
10 Year+10.66%

Asset Allocation

Stocks: 98.24%
Bonds: 0.15%
Other: 1.60%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company11.34%
JNJJOHNSON AND JOHNSON8.91%
ABBVAbbvie Inc Health Care5.94%
NOVN:SMNovartis Ag__05.53%
MRKMerck & Co. Inc.5.33%
Top 10 Concentration: 57.52%Report Date: Feb 28, 2026
Download all 119 holdings for PCHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.73%
Frequency
Annually
Latest Distribution
$5.45
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how PCHSX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

PCHSX Mutual Fund Overview

PCHSX Mutual Fund (Putnam Global Health Care Fund Class C) is managed by Putnam Investments with $30.5M in net assets. PCHSX expense ratio is 1.79%, holding 119 positions across sectors including Health Care, Unknown, Other. Inception date: 1999-07-26.

PCHSX performance shows a YTD return of 3.60%. The 1-year return is 20.62% and the 5-year return is 13.08%. PCHSX dividend yield stands at 2.73%, paid annually.

PCHSX top holdings include Eli Lilly And Company (11.3%), JOHNSON AND JOHNSON (8.9%), Abbvie Inc Health Care (5.9%), Novartis Ag__0 (5.5%), Merck & Co. Inc. (5.3%). View all PCHSX holdings, sector breakdown, or dividend history.

PCHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PCHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.